- Home
- TRAK vs EBS Comparison
TRAK vs EBS Comparison
Compare TRAK & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRAK
- EBS
- Stock Information
- Founded
- TRAK 1990
- EBS 1998
- Country
- TRAK United States
- EBS United States
- Employees
- TRAK N/A
- EBS N/A
- Industry
- TRAK EDP Services
- EBS Biotechnology: Pharmaceutical Preparations
- Sector
- TRAK Technology
- EBS Health Care
- Exchange
- TRAK Nasdaq
- EBS Nasdaq
- Market Cap
- TRAK 390.1M
- EBS 393.9M
- IPO Year
- TRAK 1998
- EBS 2006
- Fundamental
- Price
- TRAK $22.73
- EBS $5.88
- Analyst Decision
- TRAK Strong Buy
- EBS Strong Buy
- Analyst Count
- TRAK 1
- EBS 3
- Target Price
- TRAK $24.00
- EBS $14.33
- AVG Volume (30 Days)
- TRAK 41.0K
- EBS 1.2M
- Earning Date
- TRAK 05-15-2025
- EBS 05-07-2025
- Dividend Yield
- TRAK 0.32%
- EBS N/A
- EPS Growth
- TRAK 14.28
- EBS N/A
- EPS
- TRAK 0.32
- EBS N/A
- Revenue
- TRAK $21,199,507.00
- EBS $965,400,000.00
- Revenue This Year
- TRAK $15.61
- EBS N/A
- Revenue Next Year
- TRAK $15.00
- EBS $19.88
- P/E Ratio
- TRAK $71.13
- EBS N/A
- Revenue Growth
- TRAK 6.99
- EBS N/A
- 52 Week Low
- TRAK $14.23
- EBS $4.02
- 52 Week High
- TRAK $25.01
- EBS $15.10
- Technical
- Relative Strength Index (RSI)
- TRAK 67.49
- EBS 57.55
- Support Level
- TRAK $21.29
- EBS $4.71
- Resistance Level
- TRAK $22.25
- EBS $6.70
- Average True Range (ATR)
- TRAK 0.58
- EBS 0.43
- MACD
- TRAK 0.09
- EBS 0.14
- Stochastic Oscillator
- TRAK 95.45
- EBS 58.79
About TRAK ReposiTrak Inc.
ReposiTrak Inc is a software as a service provider with extensive capabilities that gives their customers an easy, cost-efficient way to expand their services to their benefit. The company and its subsidiaries develop, market, and support proprietary software products. These products assist the management of business operations, which helps clients to make more informed decisions. The company also provides a cloud-based solution to remain in compliance with business records and regulatory requirements. The firm's services comprise implementation, business optimization, outsourcing, technical services, education, and application hosting.
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company operates across three different segments, namely Commercial, Products, and Services. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.